Erickson v. Upjohn Co.

Good Law
78 F.3d 592·1996 WL 95249·1996 U.S. App. LEXIS 13601
United States Court of Appeals for the Ninth CircuitMarch 5, 199695-35207California1,746 words

Opinion

Opinion

78 F.3d 592 NOTICE: Ninth Circuit Rule 36-3 provides that dispositions other than opinions or orders designated for publication are not precedential and should not be cited except when relevant under the doctrines of law of the case, res judicata, or collateral estoppel. Andrew ERICKSON, for himself and as Personal Representative of the Estate of Phillipa Erickson, and Craig Erickson, Plaintiff-Appellant, v. The UPJOHN COMPANY, a foreign corporation, Defendant-Appellee. No. 95-35207. United States Court of Appeals, Ninth Circuit. Argued and Submitted Feb. 8, 1996. Decided March 5, 1996. 1 Before: HALL and TROTT, Circuit Judges, and RAFEEDIE, District Judge. * 2 MEMORANDUM ** 3 Phillipa Erickson committed suicide in 1987. Nearly seven years later, plaintiffs (Andrew Erickson, for himself and as personal representative of Phillipa Erickson's estate, and his son Craig Erickson) filed an action against The Upjohn Company alleging that a drug Upjohn manufactured, Halcion, contributed to Phillipa's depression and eventual suicide. The district court granted summary judgment in favor of Upjohn holding: (1) plaintiffs' claims for violations of the Washington Product Liability Act,…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.